TickerFacts.

Guardant Health, Inc. (GH): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$397.51M
Year ended 2025-12-31
-$431.80M
Trailing 12 months to 2026-06-30
2016-12-31: -$40.15M2017-12-31: -$71.41M2018-12-31: -$85.81M2019-12-31: -$70.96M2020-12-31: -$238.88M2021-12-31: -$388.73M2022-12-31: -$508.42M2023-12-31: -$521.84M2024-12-31: -$401.21M2025-12-31: -$397.51M-$397.51M
2016-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$397.51Mn/m2026-02-19, From 2025-01-01
2024-12-31-$401.21Mn/m2026-02-19, From 2024-01-01
2023-12-31-$521.84Mn/m2026-02-19, From 2023-01-01
2022-12-31-$508.42Mn/m2025-02-20, From 2022-01-01
2021-12-31-$388.73Mn/m2024-02-22, From 2021-01-01
2020-12-31-$238.88Mn/m2023-02-23, From 2020-01-01
2019-12-31-$70.96Mn/m2022-02-24, From 2019-01-01
2018-12-31-$85.81Mn/m2021-02-25, From 2018-01-01
2017-12-31-$71.41Mn/m2020-03-02, From 2017-01-01
2016-12-31-$40.15Mn/a2019-03-19, From 2016-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Guardant Health, Inc. (GH)2025-12-31-$397.51Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$67.73Mn/m
Veracyte, Inc. (VCYT)2025-12-31$79.19M+100.0%
RadNet, Inc. (RDNT)2025-12-31$198.09M-13.8%
Natera, Inc. (NTRA)2025-12-31-$268.15Mn/m
CareDx, Inc. (CDNA)2025-12-31-$15.76Mn/m
Fortrea Holdings Inc. (FTRE)2025-12-31-$794.60Mn/m
Castle Biosciences Inc (CSTL)2025-12-31-$2.04Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31-$66.97Mn/m

Compare GH, CAI, VCYT, RDNT side by side · Screen every company in Services-Medical Laboratories ↗